Dean Page, MD
Plastic Surgery · Aiken, SCNPI 1164491296
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Galderma Laboratories, L.p. at 56.7% of the total. Reporting peaked in 2019 at $295 and has fallen 76.2% since, to $70 in 2025. That places this record below the midpoint for plastic surgery clinicians in SC, where the typical reported total is $2,542.
Across 47 payments — averaging $18.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$485
- Mentor Worldwide LLC$158
- Sientra, Inc.$38
- Organogenesis Inc.$35
- Acelrx Pharmaceuticals, Inc.$35
- Integra Lifesciences Corporation$26
- plus $79 from 4 others
What the payments were for
- Food & beverage$855100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 35 | $485 |
| Mentor Worldwide LLC | 3 | $158 |
| Sientra, Inc. | 2 | $38 |
| Organogenesis Inc. | 1 | $35 |
| Acelrx Pharmaceuticals, Inc. | 1 | $35 |
| Integra Lifesciences Corporation | 1 | $26 |
| Merck | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Smith+Nephew | 1 | $21 |
| AbbVie | 1 | $14 |
How this compares
$855 in reported general payments places this provider in the 20th percentile of 65 plastic surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 13 | $330 |
| Gabapentin | 11 | $68 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $45 |
| Cephalexin | 16 | $43 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Aiken
- Richard WassermannColumbia$77K
- Kayla HumenanskyColumbia$26K
- Gregory SextonColumbia$21K
- Jason UlmCharleston$16K
- Isis Raulino ScomacaoCharleston$15K
- Rodney YoungNorth Charleston$11K
- Margaret LuthringerSpartanburg$10K
- Ram KalusMount Pleasant$9K
- Frederick WenigerBluffton$8K
- Donna MullnerCharleston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.